Syros Pharmaceuticals, Inc. Financial Ratios — SYRS Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	-74.02	-86.55	-95.63	-99.02	-98.49	-88.9	-227.94
Return on Assets (%)	- -	-56.73	-70.75	-63.61	-67.24	-58.77	-46.27	-43.7	-44.29	-79.76
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	-9,217.03	-14,728.71	-4,828.25	-3,058.15	-3,785.02	-525.16	-410.43	-831.03	-1,250.47
Operating Margin (%)	- -	-9,406.94	-15,130.28	-4,966.94	-3,136.39	-3,922.35	-545.27	-423.28	-849.21	-1,273.14
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-9,406.31	-15,060.88	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Profit Margin (%)	- -	-9,406.31	-15,060.88	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Net Income to Common Margin (%)	- -	-10,962.78	-16,222.08	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	14.14	14.2	7.16	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-74.02	-86.55	-95.63	-99.02	-98.49	-88.9	-227.94

Credit (USD)

Credit Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	- -	- -	- -	- -	- -	26	66	65	64	62
ST Debt	- -	- -	- -	- -	- -	1	2	2	2	9
LT Debt	- -	- -	- -	- -	- -	25	64	63	62	53
Total Debt/EBITDA	- -	-0.01	- -	- -	- -	-0.35	-0.84	-0.68	-0.51	-0.5
Net Debt/EBITDA	4.58	1.23	1.25	0.61	0.8	0.55	1.7	0.54	1.03	0.79
Total Debt/EBIT	- -	-0.01	- -	- -	- -	-0.33	-0.8	-0.66	-0.5	-0.49
Net Debt/EBIT	4.5	1.2	1.22	0.59	0.78	0.53	1.63	0.52	1	0.78
EBITDA to Interest Expense	- -	- -	- -	- -	-62,692	-1,041.93	-44.23	-24.67	-29.91	-24.23
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-64,076	-1,217.46	-46.09	-24.99	-30.21	-24.29
EBIT to Interest Expense	- -	- -	- -	- -	-64,296	-1,079.74	-45.92	-25.45	-30.57	-24.67
Interest Expense	- -	- -	- -	- -	- -	- -	2	4	4	5
Common Equity/Total Assets	-35.41	-109.93	88.26	83.23	73.61	52.8	42.46	46.58	52.25	9.91
Long-Term Debt/Equity (%)	- -	0.61	0.07	0.01	0.03	31.12	71.21	74.14	48.15	318.59
Long-Term Debt/Capital (%)	- -	0.6	0.07	0.01	0.03	23.44	41.13	42.01	32.15	67.42
Long-Term Debt/Total Assets (%)	- -	0.47	0.06	0.01	0.02	16.43	30.24	34.54	25.15	31.56
Total Debt/Equity (%)	- -	1	0.27	0.08	0.04	32.73	73.12	76.5	49.77	372.55
Total Debt/Capital (%)	- -	0.99	0.27	0.08	0.04	24.66	42.24	43.34	33.23	78.84
Total Debt/Total Assets (%)	- -	0.78	0.24	0.07	0.03	17.28	31.05	35.64	26	36.91
Net Debt to Equity	-100.25	-105.46	-72.69	-49.3	-63.48	-52.34	-148.46	-61.07	-99.28	-589.98
Net Debt/Capital (%)	39,732.24	2,360.88	-263.49	-97.08	-173.63	-65.1	780.77	-89.57	-531.95	161.71
EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
EBITDA-CapEx	-13	-30	-49	-54	-64	-88	-83	-98	-125	-125
Operating Income (Loss)	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	48.24	4.51	8.74	5.8	5.1	3.89	6.08	4.14	6.57	3.8
Current Ratio	48.36	4.58	8.94	5.89	5.21	4.87	6.24	4.33	6.87	3.95
Quick Ratio	48.24	4.51	8.83	5.8	5.1	4.74	6.16	4.23	6.63	3.8
CFO/Avg Current Liab	- -	-5	-4.63	-4.07	-2.52	-2.8	-2.2	-3.31	-3.95	-3.25
Common Equity/Total Assets	-35.41	-109.93	88.26	83.23	73.61	52.8	42.46	46.58	52.25	9.91
Long-Term Debt/Equity (%)	- -	0.61	0.07	0.01	0.03	31.12	71.21	74.14	48.15	318.59
Long-Term Debt/Capital (%)	- -	0.6	0.07	0.01	0.03	23.44	41.13	42.01	32.15	67.42
Long-Term Debt/Total Assets (%)	- -	0.47	0.06	0.01	0.02	16.43	30.24	34.54	25.15	31.56
Total Debt/Equity (%)	- -	1	0.27	0.08	0.04	32.73	73.12	76.5	49.77	372.55
Total Debt/Capital (%)	- -	0.99	0.27	0.08	0.04	24.66	42.24	43.34	33.23	78.84
Total Debt/Total Assets (%)	- -	0.78	0.24	0.07	0.03	17.28	31.05	35.64	26	36.91
CFO/Total Liabilities	-955.23	-240.35	-378.1	-339.78	-143.06	-85.11	-46.75	-101.87	-105.41	-72.41
CFO/CapEx	-59.55	-19.58	-17.46	-54.48	-29.13	-4.77	-17.2	-79.95	-99.17	-403.33
Altman's Z-Score	-0.1	-3.18	13.63	7.59	0.11	-1.16	0.15	-3.28	-3.58	-6.85

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	- -	- -	0.73	2.54	- -	0.2	1.51	6,710.86	- -	- -
Days Sales Outstanding	- -	- -	499.14	143.71	- -	1,841.57	241.92	0.05	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	- -	- -	284	257	188	300	610	202	73	206
- Cash & Cash Equivalents	60	36	59	32	50	41	174	92	167	140
+ Preferred Equity and Hybrid Capital	82	82	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	26	66	65	64	62
Enterprise Value	22	46	201	185	88	234	502	137	-66	129
Total Capital	60	34	81	65	79	105	157	150	191	79
Total Debt/Capital (%)	- -	0.99	0.27	0.08	0.04	24.66	42.24	43.34	33.23	78.84
Total Debt / EV	- -	0.01	- -	- -	- -	0.11	0.13	0.48	-0.96	0.48
EV/Sales	- -	146.51	633.88	168.12	43.14	118.15	33.28	5.83	- -	12.94
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	154	247	182	278	500	204	45	221
Diluted Enterprise Value	22	46	96	215	132	262	392	177	-59	143
EV per Share	9.5	20.41	85.94	70.05	26.19	54	89.33	22.09	- -	4.86
TTM Sales	- -	- -	- -	1	2	2	15	23	15	10
TTM EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
TTM Operating Income	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126
TTM Cash Flow to Firm	-12	-23	-41	-45	-40	-60	-56	-96	-119	-105
TTM Free Cash Flow to Firm	-12	-22	-38	-44	-39	-48	-52	-94	-118	-104

Multiples (USD)

Valuation Multiples API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	- -	- -	-4.04	-5.63	-4.67	-5.84	-9.25	-2.07	-0.37	-2.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	22	46	201	185	88	234	502	137	-66	129
Low Price	- -	- -	81.6	63	54	44.5	42.6	32.3	3.02	2.09
EV/Sales	- -	146.51	633.88	168.12	43.14	118.15	33.28	5.83	- -	12.94
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-3.31	-7.08	-5.58	-3.93	-4.98	-4.52	-1.32	-0.61
Price/Earnings High	- -	- -	-5.31	-11.47	-7.27	-6.36	-8.58	-11.19	-5.14	-1.39
Price/Earnings Low	- -	- -	-2.01	-2.96	-2.83	-2.37	-2.33	-2.33	-0.4	-0.36
Price/Book Value	- -	- -	3.53	3.94	2.39	3.78	6.74	2.37	0.57	12.37
Price/Book Value Average	- -	- -	3.88	6.09	4.57	4.03	5.64	4.56	1.57	5.66
Price/Book Value High	- -	- -	6.24	9.86	5.96	6.53	9.72	11.27	6.11	12.78
Price/Book Value Low	- -	- -	2.37	2.55	2.32	2.44	2.64	2.35	0.48	3.32
Price/Tangible Book Value	- -	- -	3.53	3.94	2.39	3.78	6.74	2.37	0.57	12.37
Price/Tangible Book Value Average	- -	- -	3.88	6.09	4.57	4.03	5.64	4.56	1.57	5.66
Price/Tangible Book Value High	- -	- -	6.24	9.86	5.96	6.53	9.72	11.27	6.11	12.78
Price/Tangible Book Value Low	- -	- -	2.37	2.55	2.32	2.44	2.64	2.35	0.48	3.32
Price/Sales	- -	- -	487.03	224.53	88.73	140.23	33.11	8.68	3.05	22.21
Price/Sales Average	- -	- -	536.2	347.29	169.39	149.48	27.7	16.67	8.39	10.16
Price/Sales High	- -	- -	861.11	562.48	220.79	242.1	47.75	41.24	32.68	22.95
Price/Sales Low	- -	- -	326.82	145.38	86.02	90.31	13	8.6	2.56	5.96
Price/Cash Flow	- -	- -	-3.81	-5.53	-4.51	-4.61	-8.71	-2.05	-0.37	-2.01
Price/Cash Flow Average	- -	- -	-4.19	-8.55	-8.61	-4.92	-7.29	-3.93	-1.02	-0.92
Price/Cash Flow High	- -	- -	-6.73	-13.85	-11.23	-7.96	-12.56	-9.73	-3.95	-2.08
Price/Cash Flow Low	- -	- -	-2.56	-3.58	-4.37	-2.97	-3.42	-2.03	-0.31	-0.54
Price/Free Cash Flow Average	- -	- -	-4.45	-8.71	-8.92	-6.22	-7.74	-3.98	-1.03	-0.92
Price/Free Cash Flow High	- -	- -	-7.14	-14.1	-11.63	-10.08	-13.34	-9.85	-3.99	-2.08
Price/Free Cash Flow Low	- -	- -	-2.71	-3.65	-4.53	-3.76	-3.63	-2.05	-0.31	-0.54
EV/Sales Average	- -	146.51	803.3	331.98	150.82	153.33	26.68	15.38	6.48	1.69
EV/Sales High	- -	146.51	1,401.65	555.78	203.97	253.21	51.16	39.75	45.45	13.63
EV/Sales Low	- -	146.51	417.73	121.99	64.62	89.54	8.73	7.38	- -	- -
EV/EBITDA Average	-1.64	-1.59	-5.45	-6.88	-4.93	-4.05	-5.08	-3.75	-0.78	-0.14
EV/EBITDA High	-1.64	-1.59	-9.52	-11.51	-6.67	-6.69	-9.74	-9.68	-5.47	-1.09
EV/EBITDA Low	-1.64	-1.59	-2.84	-2.53	-2.11	-2.37	-1.66	-1.8	0.35	0.18
EV/EBIT Average	-1.61	-1.56	-5.31	-6.68	-4.81	-3.91	-4.89	-3.63	-0.76	-0.13
EV/EBIT High	-1.61	-1.56	-9.26	-11.19	-6.5	-6.46	-9.38	-9.39	-5.35	-1.07
EV/EBIT Low	-1.61	-1.56	-2.76	-2.46	-2.06	-2.28	-1.6	-1.74	0.34	0.18
Last Price	- -	- -	121.6	97.3	55.7	69.1	108.5	32.6	3.59	7.79
High Price	- -	- -	215	243.75	138.6	119.3	156.5	154.9	38.5	8.05
Enterprise Value Average	22	46	255	366	309	304	403	361	96	17
Enterprise Value High	22	46	444	612	418	502	772	934	676	135
Enterprise Value Low	22	46	132	134	132	177	132	173	-43	-22

Shares Outstanding	2	2	2	3	3	4	6	6	20	26
Diluted Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Basic Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Revenue per Share	- -	1.28	0.25	0.43	0.63	0.49	3.28	3.76	1.18	0.35
EBITDA per Share	-53.23	-118.03	-36.77	-20.92	-19.2	-18.65	-17.21	-15.42	-9.79	-4.39
Operating Income per Share	-54.27	-120.46	-37.78	-21.52	-19.69	-19.33	-17.87	-15.9	-10	-4.47
Basic EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Basic EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-48.35	-93.03	-31.93	-17.61	-12.35	-14.98	-12.46	-15.92	-9.74	-3.87
Free Cash Flow per Basic Share	-49.16	-97.78	-33.76	-17.93	-12.77	-18.12	-13.18	-16.12	-9.84	-3.88
Cash & Equivalents per Share	26.53	15.78	35.75	27.27	29.52	21.08	30.95	21.02	9.98	5.28
Book Value per Share	-9.57	-21.07	34.47	24.72	23.27	18.26	16.11	13.74	6.3	0.63
Tangible Book Value per Share	-9.57	-21.07	34.47	24.72	23.27	18.26	16.11	13.74	6.3	0.63

Syros Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)